Evaluation of published case reports' standards and notification

Drug Information Journal

Volumn 36, Issue 2, 2002, Pages 303-307

  Ferguson, Jeffrey A ^a   Mockbee, Collen ^a   Erbele, Sara ^a   Muniz, Edmundo ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Adverse events; Case reports; CIOMS V; Regulatory guidelines; Uniform requirements for manuscripts

Indexed keywords

CASE REPORT; CONFERENCE PAPER; DATA ANALYSIS; DRUG CONTROL; DRUG INDUSTRY; DRUG INFORMATION; DRUG SAFETY; HUMAN; ORGANIZATION; POLICY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PUBLICATION;

EID: 0036374917     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150203600208     Document Type: Conference Paper

References (7)

1. Venulet J. Informativity of adverse drug reactions data in medical publications. Drug Inf J. 1985;19:357-365.
2. Venulet J, Blattner R, von Billow J, Berneker G-C. How good are articles on adverse drug reactions? Br Med J. 1982;284:252-254.
3. Venulet J. Improving reports of adverse drug reactions. Br Med J. 1984;289:898.
4. Berneker G-C, Ciucci AG, Joyce I. Standards for reporting adverse drug reactions. Br Med J. 1983; 287:1720.
5. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Ann Int Med. 1997;126:36-47. www.icmje.org.
6. Council for International Organizations of Medical Sciences Working Group V. Current Challenges in Pharmacovigilance: Pragmatic Approaches. Geneva, Switzerland: Council for International Organizations of Medical Sciences; 2001.
7. Institute for Scientific Information. 2000 JCR Journal Citation Reports, Science Addition. Philadelphia, PA: Institute for Scientific Information; 2001.